Gilead Sciences (GILD) Shares Repurchased (2009 - 2026)

Gilead Sciences has reported Shares Repurchased for 18 years, with the latest figure at $419.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Repurchased fell 42.6% year-over-year to $419.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (up 8.85% YoY), and the FY2025 full-year result was $1.9 billion, up 67.13% from the prior year.
• Shares Repurchased for Q1 2026 stood at $419.0 million, up from $230.0 million in the prior quarter.
• The five-year high for Shares Repurchased was $792.0 million in Q4 2022, with the low at $72.0 million in Q2 2022.
• Historically, Shares Repurchased has averaged $346.3 million across 5 years, with a median of $350.0 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Repurchased jumped 1516.33% — and 2023, when it slumped 81.06%.
• Gilead Sciences' Shares Repurchased stood at $792.0 million in 2022, then tumbled by 81.06% to $150.0 million in 2023, then soared by 133.33% to $350.0 million in 2024, then sank by 34.29% to $230.0 million in 2025, then jumped by 82.17% to $419.0 million in 2026.
• The last three Shares Repurchased figures came in at $419.0 million (Q1 2026), $230.0 million (Q4 2025), and $435.0 million (Q3 2025), per Business Quant data.